BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 9264176)

  • 1. Clinical symptom dimensions and deficits on the Continuous Performance Test in schizophrenia.
    Liu SK; Hwu HG; Chen WJ
    Schizophr Res; 1997 Jun; 25(3):211-9. PubMed ID: 9264176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The complex relationships between executive functions and positive symptoms in schizophrenia.
    Guillem F; Rinaldi M; Pampoulova T; Stip E
    Psychol Med; 2008 Jun; 38(6):853-60. PubMed ID: 18261245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Internal consistency, temporal stability and neuropsychological correlates of three cognitive components of the Positive and Negative Syndrome Scale (PANSS).
    Bryson G; Bell M; Greig T; Kaplan E
    Schizophr Res; 1999 Jul; 38(1):27-35. PubMed ID: 10427608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symptom structure in schizophrenia: two-, three- or four-factor models?
    Dollfus S; Everitt B
    Psychopathology; 1998; 31(3):120-30. PubMed ID: 9636941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disorganization syndrome is correlated to working memory deficits in unmedicated schizophrenic patients with recent onset schizophrenia.
    Daban C; Amado I; Baylé F; Gut A; Willard D; Bourdel MC; Loo H; Olié JP; Millet B; Krebs MO; Poirier MF
    Schizophr Res; 2003 Jun; 61(2-3):323-4. PubMed ID: 12729884
    [No Abstract]   [Full Text] [Related]  

  • 6. Differential relationships between positive and negative symptoms and neuropsychological deficits in schizophrenia.
    Berman I; Viegner B; Merson A; Allan E; Pappas D; Green AI
    Schizophr Res; 1997 May; 25(1):1-10. PubMed ID: 9176922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A four-dimensional model of chronic schizophrenia based on the factorial structure of the Positive and Negative Syndrome Scale (PANSS). A study of a group of 153 chronic schizophrenic patients and comparison with the factorial structure of the BPRS].
    Loas G; Noisette C; Legrand A; Delahousse J
    Encephale; 1997; 23(1):10-8. PubMed ID: 9172962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive and negative symptoms in the psychoses: multidimensional scaling of SAPS and SANS items.
    Moranville JT
    Schizophr Res; 1993 Oct; 10(3):277-8. PubMed ID: 8260447
    [No Abstract]   [Full Text] [Related]  

  • 9. [Psychometric properties of PANSS (Positive and Negative Syndrome Scale) in the French version in a sample of schizophrenic patients].
    Lançon C; Auquier P; Llorca PM; Martinez JL; Bougerol T; Scotto JC
    Encephale; 1997; 23(1):1-9. PubMed ID: 9172961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A factor analytic study of symptoms in acute schizophrenia.
    Mellers JD; Sham P; Jones PB; Toone BK; Murray RM
    Acta Psychiatr Scand; 1996 Feb; 93(2):92-8. PubMed ID: 8686489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The PANSS (Positive And Negative Symptom) Scale].
    Guelfi JD
    Encephale; 1997 Apr; 23 Spec No 2():35-8. PubMed ID: 9273305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disorganization and cognitive impairment in schizophrenia: independent symptom dimensions?
    Klingberg S; Wittorf A; Wiedemann G
    Eur Arch Psychiatry Clin Neurosci; 2006 Dec; 256(8):532-40. PubMed ID: 17164977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scales to measure dimensions of hallucinations and delusions: the psychotic symptom rating scales (PSYRATS).
    Haddock G; McCarron J; Tarrier N; Faragher EB
    Psychol Med; 1999 Jul; 29(4):879-89. PubMed ID: 10473315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Psychotic Symptom Rating Scales (PSYRATS): their usefulness and properties in first episode psychosis.
    Drake R; Haddock G; Tarrier N; Bentall R; Lewis S
    Schizophr Res; 2007 Jan; 89(1-3):119-22. PubMed ID: 17095193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symptom patterns and subgrouping of schizophrenic patients: significance of negative symptoms assessed on admission.
    Hwu HG; Chen CH; Hwang TJ; Liu CM; Cheng JJ; Lin SK; Liu SK; Chen CH; Chi YY; Ou-Young CW; Lin HN; Chen WJ
    Schizophr Res; 2002 Jul; 56(1-2):105-19. PubMed ID: 12084425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validity of the depressive dimension extracted from principal component analysis of the PANSS in drug-free patients with schizophrenia.
    El Yazaji M; Battas O; Agoub M; Moussaoui D; Gutknecht C; Dalery J; d'Amato T; Saoud M
    Schizophr Res; 2002 Jul; 56(1-2):121-7. PubMed ID: 12084426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Item response analysis of the Positive and Negative Syndrome Scale.
    Santor DA; Ascher-Svanum H; Lindenmayer JP; Obenchain RL
    BMC Psychiatry; 2007 Nov; 7():66. PubMed ID: 18005449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between symptom dimensions and neurocognitive functioning in schizophrenia: a meta-analysis of WCST and CPT studies. Wisconsin Card Sorting Test. Continuous Performance Test.
    Nieuwenstein MR; Aleman A; de Haan EH
    J Psychiatr Res; 2001; 35(2):119-25. PubMed ID: 11377441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three syndrome concept of schizophrenia. A factor analytic study.
    Malla AK; Norman RM; Williamson P; Cortese L; Diaz F
    Schizophr Res; 1993 Aug; 10(2):143-50. PubMed ID: 8398946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive or negative symptoms--which are more appropriate as diagnostic criteria for schizophrenia?
    Klosterkötter J; Albers M; Steinmeyer EM; Hensen A; Sass H
    Acta Psychiatr Scand; 1995 Nov; 92(5):321-6. PubMed ID: 8619335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.